posted on 1999-02-10, 00:00authored byRichard M. Keenan, James F. Callahan, James M. Samanen, William E. Bondinell, Raul R. Calvo, Lichong Chen, Charles DeBrosse, Drake S. Eggleston, R. Curtis Haltiwanger, Shing Mei Hwang, Dalia R. Jakas, Thomas W. Ku, William H. Miller, Kenneth A. Newlander, Andrew Nichols, Michael F. Parker, Linda S. Southhall, Irene Uzinskas, Janice A. Vasko-Moser, Joseph W. Venslavsky, Angela S. Wong, William F. Huffman
Previously, we reported the direct design of highly potent nonpeptide 3-oxo-1,4-benzodiazepine
fibrinogen receptor antagonists from a constrained, RGD-containing cyclic semipeptide. The
critical features incorporated into the design of these nonpeptides were the exocyclic amide at
the 8-position which overlaid the Arg carbonyl, the phenyl ring which maintained an extended
Gly conformation, and the diazepine ring which mimicked the γ-turn at Asp. In this paper, we
investigate conformational preferences of the 8-substituted benzodiazepine analogues by
examining structural modifications to both the exocyclic amide and the seven-membered
diazepine ring and by studying the conformation of the benzodiazepine ring using molecular
modeling, X-ray crystallography, and NMR. We found that the directionality of the amide at
the 8-position had little effect on activity and the (E)-olefin analogue retained significant
potency, indicating that the trans orientation of the amide, and not the carbonyl or NH groups,
made the largest contribution to the observed activity. For the diazepine ring, with the exception
of the closely analogous 3-oxo-2-benzazepine ring system described previously, all of the
modifications led to a significant reduction in activity compared to the potent 3-oxo-1,4-benzodiazepine parent ring system, implicating this particular type of ring system as a desirable
structural feature for high potency. Energy minimizations of a number of the modified analogues
revealed that none could adopt the same low-energy conformation as the one shared by the
active (S)-isomer of the 3-oxo-1,4-benzodiazepines and 3-oxo-2-benzazepines. The overall data
suggest that the features contributing to the observed high potency in this series are the
orientation of the 3−4 amide and the conformational constraint imposed by the seven-membered
ring, both of which position the key acidic and basic groups in the proper spatial relationship.